Consequently, ABCA1 down-regulation during AD would disrupt BBB integrity, generate pro-inflammatory signaling and decrease ApoE lipidation with subsequent Aβ aggregation and less trafficking into the perivascular spaces to be eliminated by LRP1. This evidence concerns the gene LRP1 and Alzheimer disease.